Recruiting Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria NCT06865651 Conditions Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +15 more Locations Ziaderm Research LLC — North Miami Beach, Florida, United States Endeavor Health — Glenview, Illinois, United States Novartis Investigative Site — Grenoble, France Novartis Investigative Site — Montpellier, France View all 17 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Omalizumab in Severe and Refractory Solar Urticaria NCT02262130 Conditions Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +13 more Locations CHU de Angers — Angers, France Dermatology department, Centre Hospitalier Régional Universitaire — Besançon, France CHU de Caen — Caen, France CHU de Dijon — Dijon, France View all 13 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Intravenous Immunoglobulins in Severe and Refractory Solar Urticaria NCT01360658 Conditions Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +13 more Locations Regional University Hospital — Besançon, France University Hospital — Caen, France University Hospital — Grenoble, France Regional University Hospital — Lille, France View more locations Show fewer locations Loading locations... View Trial Details
Completed Phase II Solar Urticaria (SU) Pilot Study NCT00859534 Conditions Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +13 more Locations Salford Royal Foundation Hospital (Hope Hospital) — Manchester, United Kingdom View Trial Details
